Abrams Eye Institute
Las Vegas, Nevada, United States
LASIK surgeon in Clark County, Nevada
6450 Medical Center St Suite #100, Las Vegas, NV 89148
About Abrams Eye Institute
"ADVANCED TECHNOLOGY FOR OPTIMAL RESULTS As a center of excellence for specialty eye care, our mission is to provide the best possible vision to our patients. To this end, we are passionately committed to provide a world-class surgical care for your patients through the use of the most advanced surgical technology – and techniques – available. Dr. Jack Abrams, and the team at Abrams Eye Institute, have conducted some of the first surgeries using specialized technology, anywhere, and remain committed to providing patients in southern Nevada with the most current technologies in care of their eyes."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Kala Pharmaceuticals, Inc.
2
Mati Therapeutics Inc.
2
Shire
1
Sun Pharmaceutical Industries Limited
1
Clinical Trials at Abrams Eye Institute
During the past decade, Abrams Eye Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis
2011-10-01
2013-06-01
Completed
917
A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
2011-11-01
2012-09-01
Completed
77
A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma
2013-12-01
2016-12-01
Completed
86
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
2014-11-06
2015-10-05
Completed
711
Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain
2016-06-01
2017-03-01
Completed
520
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
2016-06-01
2017-09-01
Completed
909
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Abrams Eye Institute
According to Clinical.Site data, the most researched conditions in "Abrams Eye Institute" are
"Blepharitis" (1 trials), "Dry Eye Disease" (1 trials), "Dry Eye Syndromes" (1 trials), "Glaucoma" (1 trials) and "Keratoconjunctivitis Sicca" (1 trials). Many other conditions were trialed in "Abrams Eye Institute" in a lesser frequency.
Clinical Trials Intervention Types at Abrams Eye Institute
Most popular intervention types in "Abrams Eye Institute" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Azasite" (1 trials), "Dexamethasone" (1 trials), "ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined)" (1 trials), "KPI-121 0.25% Ophthalmic Suspension" (1 trials) and "KPI-121 1% Ophthalmic Suspension dosed BID" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Abrams Eye Institute
The vast majority of trials in "Abrams Eye Institute" are
6 trials for "All" genders.
Clinical Trials Status at Abrams Eye Institute
Currently, there are NaN active trials in "Abrams Eye Institute".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Abrams Eye Institute,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Abrams Eye Institute, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".